Related Experiment Video
Updated: Jul 12, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
TMPRSS2 is a functional receptor for human coronavirus HKU1
Nell Saunders1, Ignacio Fernandez2, Cyril Planchais3
1Virus & Immunity Unit, Institut Pasteur, Université de Paris Cité, CNRS UMR 3569, Paris, France.
Abstract:
Four endemic seasonal human coronaviruses causing common colds circulate worldwide: HKU1, 229E, NL63 and OC43 (ref. 1). After binding to cellular receptors, coronavirus spike proteins are primed for fusion by transmembrane serine protease 2 (TMPRSS2) or endosomal cathepsins2-9. NL63 uses angiotensin-converting enzyme 2 as a receptor10, whereas 229E uses human aminopeptidase-N11. HKU1 and OC43 spikes bind cells through 9-O-acetylated sialic acid, but their protein receptors remain unknown12. Here we show that TMPRSS2 is a functional receptor for HKU1. TMPRSS2 triggers HKU1 spike-mediated cell-cell fusion and pseudovirus infection. Catalytically inactive TMPRSS2 mutants do not cleave HKU1 spike but allow pseudovirus infection. Furthermore, TMPRSS2 binds with high affinity to the HKU1 receptor binding domain (Kd 334 and 137 nM for HKU1A and HKU1B genotypes) but not to SARS-CoV-2. Conserved amino acids in the HKU1 receptor binding domain are essential for binding to TMPRSS2 and pseudovirus infection. Newly designed anti-TMPRSS2 nanobodies potently inhibit HKU1 spike attachment to TMPRSS2, fusion and pseudovirus infection. The nanobodies also reduce infection of primary human bronchial cells by an authentic HKU1 virus. Our findings illustrate the various evolution strategies of coronaviruses, which use TMPRSS2 to either directly bind to target cells or prime their spike for membrane fusion and entry.
Insights
Transmembrane serine protease 2 (TMPRSS2) acts as a direct receptor for the HKU1 coronavirus, facilitating cell entry and infection. This discovery reveals a novel viral binding strategy and potential therapeutic target for common cold coronaviruses.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Four endemic human coronaviruses (HKU1, 229E, NL63, OC43) cause common colds globally.
- Coronavirus entry relies on spike protein priming by cellular proteases like TMPRSS2 or cathepsins.
- Receptors for HKU1 and OC43 spikes remain unidentified, unlike NL63 (ACE2) and 229E (hAPN).
Purpose of the Study:
- To identify the cellular receptor for the HKU1 coronavirus.
- To elucidate the mechanism of HKU1 entry and potential therapeutic interventions.
Main Methods:
- Investigated TMPRSS2 as a functional receptor for HKU1.
- Assessed HKU1 spike-mediated cell-cell fusion and pseudovirus infection.
- Utilized catalytically inactive TMPRSS2 mutants and anti-TMPRSS2 nanobodies.
- Performed binding affinity studies and tested inhibition of authentic HKU1 virus infection.
Main Results:
- TMPRSS2 directly binds to the HKU1 spike protein, acting as a functional receptor.
- TMPRSS2 triggers HKU1 spike-mediated cell-cell fusion and pseudovirus infection.
- Anti-TMPRSS2 nanobodies effectively inhibit HKU1 attachment, fusion, and infection in cell cultures and primary bronchial cells.
Conclusions:
- TMPRSS2 serves as a direct receptor for HKU1, distinct from its role in priming other coronaviruses.
- This finding highlights diverse coronavirus evolutionary strategies for cell binding and entry.
- Targeting TMPRSS2 with nanobodies presents a promising therapeutic strategy against HKU1 infections.

